Clinical Trials Directory

Trials / Completed

CompletedNCT05594069

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
87 (actual)
Sponsor
Peking University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the intervention effect of triple pre-rehabilitation on head and neck cancer patients with radiotherapy, and process evaluation to further optimize the intervention program. The pre-rehabilitation intervention was develped previously based on the process of evidence-based-nursing, including interventions of nurtrtion, exercise, and psychology.

Conditions

Interventions

TypeNameDescription
OTHERtriple pre-rehabilitationThe triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out from the time of enrollment (T0). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.
OTHERtriple rehabilitationThe triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out at the time of the beginning of radiotherapy (T1), and the middle stage of radiotherapy (T2). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.

Timeline

Start date
2022-11-24
Primary completion
2023-07-13
Completion
2023-10-30
First posted
2022-10-26
Last updated
2023-11-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05594069. Inclusion in this directory is not an endorsement.